Gian Marco Werro
Gian Marco Werro is an equity analyst at Zürcher Kantonalbank, specializing in pharmaceutical and biotechnology sectors. He is known for his insightful analyses of market trends and company performance, particularly in relation to innovative treatments like Nemluvio, which has contributed significantly to Galderma's impressive growth in recent years.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Gian Marco Werro, an analyst at Zürcher Kantonalbank, commented on the potential of Nemluvio and its impact on Galderma's revenue.
7